4.7 Article

Cardiometabolic Implications of Postpartum Weight Changes in the First Year After Delivery

Journal

DIABETES CARE
Volume 37, Issue 7, Pages 1998-2006

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc14-0087

Keywords

-

Funding

  1. Canadian Institutes of Health Research [MOP-84206]
  2. Heart and Stroke Foundation of Ontario [NA6747]
  3. Canadian Diabetes Association [OG-3-10-3051-BZ, OG-3-11-3300-RR]

Ask authors/readers for more resources

OBJECTIVE The cumulative effect of postpartum weight retention from each pregnancy in a woman's life may contribute to her ultimate risk of diabetes and vascular disease. However, there is little direct evidence supporting this hypothesis. In this context, we sought to evaluate the cardiometabolic implications of patterns of postpartum weight change and the time course thereof in the first year after pregnancy. RESEARCH DESIGN AND METHODS Three hundred five women underwent cardiometabolic characterization at recruitment in pregnancy and at 3 and 12 months postpartum. Based on their respective weight changes between prepregnancy and 3 months postpartum(loss or gain) and between 3 and 12 months postpartum (loss or gain), participants were stratified into four groups: loss/loss, gain/loss, loss/gain, and gain/gain. RESULTS Most women (81.0%) had higher weight at 3 months postpartum compared with prepregnancy. Between 3 and 12 months, most women (74.4%) lost weight. At 3 months, there were modest differences between the four groups in mean adjusted LDL cholesterol (P = 0.01) and apolipoprotein-B (apoB; P = 0.02) but no significant differences in adjusted blood pressure, fasting and 2-h glucose, HDL, triglycerides, homeostasis model assessment of insulin resistance (HOMA-IR), adiponectin, and C-reactive protein. By 12 months postpartum, however, clear gradients emerged, with mean adjusted diastolic blood pressure (P = 0.02), HOMA-IR (P = 0.0003), LDL (P = 0.001), and apoB (P < 0.0001) all progressively increasing from the loss/loss group to gain/loss to loss/gain to gain/gain. Similarly, at 12 months, mean adjusted adiponectin showed a stepwise decrease from loss/loss to gain/loss to loss/gain to gain/gain (P = 0.003). CONCLUSIONS An adverse cardiometabolic profile emerges as early as 1 year postpartum in women who do not lose weight between 3 and 12 months after delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Oxcarbazepine was associated with risks of newly developed hypothyroxinaemia and impaired central set point of thyroid homeostasis in schizophrenia patients

Desheng Zhai, Jinni Chen, Baoqiang Guo, Ravi Retnakaran, Songyin Gao, Xiangyang Zhang, Wei Hao, Ruiling Zhang, Ying Zhao, Shi Wu Wen

Summary: This study showed that the use of oxcarbazepine was associated with a higher risk of developing hypothyroxinaemia and a greater reduction in central set point of thyroid homeostasis.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Letter Medicine, General & Internal

Analysis of Preconception Paternal Smoking and Neonatal Outcomes

Jennifer Horwitz, Shi Wu Wen, Hongzhuan Tan, Shujin Zhou, Chang Ye, Minxue Shen, Ravi Retnakaran

Summary: This cohort study examines the relationship between preconception paternal smoking and neonatal outcomes.

JAMA NETWORK OPEN (2022)

Article Obstetrics & Gynecology

Folic Acid Supplementation in Early Pregnancy, Homocysteine Concentration, and Risk of Gestational Diabetes Mellitus

Yanfang Guo, Rong Luo, Daniel J. Corsi, Ruth Rennicks White, Graeme Smith, Marc Rodger, Ravi Retnakaran, Mark Walker, Shi Wu Wen

Summary: This study aimed to evaluate the impact of early pregnancy folic acid supplementation on the risk of gestational diabetes mellitus. The results showed no significant associations between folic acid supplementation, homocysteine levels, methylenetetrahydrofolate reductase 677 TT genotype, and gestational diabetes mellitus.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2022)

Letter Endocrinology & Metabolism

The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation

Mireille N. M. van Poppel, Ravi Retnakaran

DIABETES & METABOLISM (2022)

Article Endocrinology & Metabolism

Treating Gestational Diabetes Reduces Birth Weight but Does Not Affect Infant Adiposity Across the 1st Year of Life

Ravi Retnakaran, Chang Ye, Anthony J. Hanley, Philip W. Connelly, Mathew Sermer, Bernard Zinman, Jill K. Hamilton

Summary: Despite reducing birth weight and macrosomia, the treatment of GDM does not have analogous effects on infant adiposity across the 1st year of life.

DIABETES CARE (2022)

Article Psychiatry

Impaired central set point of thyroid homeostasis during quetiapine treatment in the acute phase of schizophrenia

Ying Zhao, Qiongge Guan, Jingyi Shi, Jiewei Sun, Qi Wang, Jianzhou Yang, Ravi Retnakaran, Jinhong Han, Xiangyang Zhang, Wei Hao, Xin Huang, Ruiling Zhang, Desheng Zhai, Shi Wu Wen

Summary: This study evaluated the impact of quetiapine treatment on the central set point of thyroid homeostasis in patients with acute phase schizophrenia. The results showed that quetiapine exposure was associated with a significant decline in thyroid indices and there was a dose-response relationship.

SCHIZOPHRENIA RESEARCH (2022)

Article Endocrinology & Metabolism

Screening Accuracy of the 50 g-Glucose Challenge Test in Twin Compared With Singleton Pregnancies

Liran Hiersch, Baiju R. Shah, Howard Berger, Michael Geary, Sarah D. McDonald, Beth Murray-Davis, Jun Guan, Ilana Halperin, Ravi Retnakaran, Jon Barrett, Nir Melamed

Summary: This study compared the screening accuracy, risk of GDM, and risk of LGA between twin and singleton pregnancies using various 50 g-GCT cutoffs. The results showed that for any given 50 g-GCT result, the probability of GDM was higher in the twin group, while the probability of LGA was lower.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Multidisciplinary Sciences

The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial

Ravi Retnakaran, Chang Ye, Alexandra Emery, Caroline K. Kramer, Bernard Zinman

Summary: In early type 2 diabetes, adding exenatide to basal insulin does not enhance beta-cell function or achieve diabetes remission, but may provide glycemic benefits during treatment.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

The association between pre-gravid and first trimester maternal weight and its implications for clinical research studies

Ravi Retnakaran, Chang Ye, Shi Wu Wen, Hongzhuan Tan

Summary: In this prospective study, the relationship between pre-gravid weight and first trimester weight was evaluated. The results showed a good concordance and correlation between the two, supporting the use of first trimester weight measurement as a surrogate for pre-pregnancy weight in clinical research.

SCIENTIFIC REPORTS (2022)

Article Medicine, General & Internal

Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease

Ravi Retnakaran, Baiju R. Shah

Summary: Women with gestational diabetes have an increased risk of cardiovascular disease, and adverse glycemic and lipid measures contribute to this elevated risk. Monitoring and intervention targeting these risk factors may help prevent cardiovascular disease in this population.

BMC MEDICINE (2022)

Article Psychiatry

Higher central set point of thyroid homeostasis in drug-na?ve patients affected by first episode schizophrenia

Desheng Zhai, Jialuo Bing, Xuchang Shan, Hu Luo, Wendy Wen, Songyin Gao, Kaijun Niu, Taizhen Cui, Hongbin Li, Ravi Retnakaran, Wei Hao, Ruiling Zhang, Ying Zhao, Shi Wu Wen

Summary: There is a higher central set point of thyroid homeostasis in drug-naive patients affected by first episode schizophrenia, which may be the underlying mechanism of thyroid allostatic load.

SCHIZOPHRENIA RESEARCH (2022)

Article Medicine, General & Internal

Association of Concomitant Gestational Hypertensive Disorders and Gestational Diabetes With Cardiovascular Disease

Justin B. Echouffo Tcheugui, Jun Guan, Longdi Fu, Ravi Retnakaran, Baiju R. Shah

Summary: Accumulating evidence suggests that gestational hypertensive disorders (GHTD) and gestational diabetes (GD) are associated with an increased risk of cardiovascular disease (CVD). However, the extent to which the co-occurrence of GHTD and GD is associated with the risk of CVD remains largely unknown.

JAMA NETWORK OPEN (2022)

Article Cardiac & Cardiovascular Systems

The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes

Ravi Retnakaran, Jiajie Pu, Chang Ye, Alexandra Emery, Caroline K. Kramer, Bernard Zinman

Summary: This study evaluated the effects of adding GLP1-RA exenatide or meal insulin lispro to basal glargine therapy on vascular function in early type 2 diabetes. The findings suggest that adding exenatide or lispro does not affect fasting endothelial function in patients with early type 2 diabetes.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Endocrinology & Metabolism

The prognostic value of the oral glucose tolerance test for future type-2 diabetes in nulliparous pregnant women testing negative for gestational diabetes

Liran Hiersch, Baiju R. Shah, Howard Berger, Michael Geary, Sarah D. McDonald, Beth Murray-Davis, Ilana Halperin, Longdi Fu, Ravi Retnakaran, Jon Barrett, Nir Melamed, DOH-NET Diabet Obesity Hypertension Pregnancy Res Network, SOON

Summary: This study aimed to determine the prognostic value of the antepartum 75g-oral glucose tolerance test (OGTT) for future type 2 diabetes mellitus (T2DM) in nulliparous pregnant women who tested negative for gestational diabetes mellitus (GDM). A population-based retrospective cohort study was conducted in Ontario, Canada from 2007 to 2017. The results showed that the antepartum OGTT can be used to refine the future risk of T2DM even in nulliparous pregnant women who tested negative for GDM. The model combining OGTT values and clinical characteristics showed a detection rate of 43% for developing T2DM at 5 years post pregnancy with a false-positive rate of 20%.

DIABETES & METABOLISM (2022)

Review Medicine, General & Internal

The life course perspective of gestational diabetes: An opportunity for the prevention of diabetes and heart disease in women

Jennifer Fu, Ravi Retnakaran

Summary: Gestational diabetes mellitus is a chronic cardiometabolic disorder in pregnancy, which identifies high-risk women for early intervention and risk modification to prevent the development of diabetes and heart disease.

ECLINICALMEDICINE (2022)

No Data Available